Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Sleep Disorder Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Sleep Disorder. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Sleep Disorder clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Research is led by University of Alabama, Tuscaloosa (1), Xuanwu Hospital, Beijing (1), Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is LOCK Sleep Program (behavioral, 1 trial), followed by No intervention (control period/baseline data collection), Deep Brain Stimulation.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Sleep Disorder trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05820919

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing...

Sponsor: University of Alabama, TuscaloosaEnrolling: 4563 locations
RECRUITINGNCT06914466

Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD

Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by both motor and non-motor symptoms. Subthalamic nucleus (STN) deep brain stimulation (DBS)...

Sponsor: Xuanwu Hospital, BeijingEnrolling: 201 location
RECRUITINGNCT05242393

The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational)

The study is aimed at the investigation of the association of biomarkers of circadian rhythms with sleep characteristics and stroke outcome in acute stroke patients. It is...

Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of HealthEnrolling: 2501 location

Frequently Asked Questions

There are currently 3 clinical trials for Sleep Disorder, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Sleep Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Sleep Disorder, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.